Corteva, Inc. $CTVA Stock Position Boosted by Ninety One UK Ltd

Ninety One UK Ltd boosted its stake in Corteva, Inc. (NYSE:CTVA) by 52.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 858,349 shares of the company’s stock after buying an additional 293,581 shares during the period. Ninety One UK Ltd’s holdings in Corteva were worth $57,535,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Activest Wealth Management boosted its holdings in shares of Corteva by 118.3% during the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after purchasing an additional 200 shares during the period. JPL Wealth Management LLC bought a new position in shares of Corteva in the third quarter valued at approximately $25,000. True Wealth Design LLC increased its position in Corteva by 209.5% during the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after acquiring an additional 264 shares during the period. Redmont Wealth Advisors LLC acquired a new stake in Corteva during the third quarter worth $29,000. Finally, Jackson Grant Investment Advisers Inc. boosted its stake in shares of Corteva by 90.6% in the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock valued at $30,000 after purchasing an additional 213 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider owned 8,090 shares in the company, valued at $619,289.50. This represents a 50.67% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. 0.15% of the stock is currently owned by corporate insiders.

Corteva Trading Down 0.9%

NYSE:CTVA opened at $80.44 on Friday. Corteva, Inc. has a twelve month low of $58.58 and a twelve month high of $85.63. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The business has a 50 day moving average price of $79.55 and a two-hundred day moving average price of $71.04. The company has a market cap of $54.00 billion, a P/E ratio of 50.91, a price-to-earnings-growth ratio of 2.77 and a beta of 0.68.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. During the same quarter in the prior year, the business posted $0.32 EPS. The business’s revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, analysts expect that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 16th. Stockholders of record on Monday, March 2nd were paid a dividend of $0.18 per share. The ex-dividend date was Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio is currently 45.57%.

Analysts Set New Price Targets

A number of research firms recently issued reports on CTVA. Citigroup lifted their price target on Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a report on Thursday, February 5th. Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. CICC Research boosted their price objective on Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a research report on Wednesday, February 11th. Mizuho boosted their price objective on Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a research report on Wednesday. Finally, Argus boosted their price objective on Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a research report on Tuesday, March 31st. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $84.52.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.